Verily Impact Investors
Verily is an Alphabet precision health company that helps pharma and consumer health companies develop safe, effective treatments faster and enable patients, providers and payors to make better care decisions
Investors
Founded Date:
2015-01-01
Total Funding:
3500000000.0
Employee Number:
1001-5000
Funding Status:
Private Equity
Number Of Exists:
4
Last Funding Type:
Secondary Market
Acquisitions Number:
Made Acquisitions
Investors Number:
6
Last Funding Date:
2022-09-28
Industry:
End-to-End Drug Development
Headquarters:
South San Francisco, California, United States
Estimated Revenue:
$100M to $500M